H2S preconditioning of human adipose tissue-derived stem cells increases their efficacy in an in vitro model of cell therapy for simulated ischemia

Dongó, Eleni and Benkő, Zsolt and Csizmazia, Ágnes and Marosi, Gabriella and Grottke, Astrid and Jücker, Manfred and Schumacher, Udo and Kiss, Levente (2014) H2S preconditioning of human adipose tissue-derived stem cells increases their efficacy in an in vitro model of cell therapy for simulated ischemia. LIFE SCIENCES. ISSN 0024-3205

Text DONGO2014_H2S preconditioning of human adipose tissue-derived stem cells increases their efficacy in an in vitro model of cell therapy for simulated ischemia.pdf Restricted to Registered users only Download (899kB) | Request a copy

Abstract

Aims: A major limitation of cell-based therapies for ischemia – reperfusion injury is the excessive loss of adminis- tered cells. We investigated whether H 2 S can improve the survival and ef fi cacy of therapeutic cells in an in vitro model of cell-based therapy for simulated ischemia. Main methods: H9c2 rat cardiomyoblasts were exposed to oxygen – glucose deprivation and NaHS (3 – 30 μ M) pretreated human adipose tissue derived stem cells (hASCs) were added after reoxygenization. Viability of both cell lines was assessed with fl ow cytometry after 24 h. The effects of H 2 S on antioxidant defense, prolifera- tion, AKT and ERK1/2 phosphorylation and mitochondrial activity were analyzed in hASCs. Proliferation was evaluated using propargylglycine, an inhibitor of endogenous H 2 S synthesis. Key fi ndings: NaHS pretreatment decreased the ratio of necrotic therapeutic cells by 41.8% in case of 3 μ M NaHS and by 34.3% with 30 μ M NaHS. The ratio of necrotic postischemic cardiomyocytes decreased by 35%, but only with the use of 3 μ M NaHS. Antioxidant defense mechanisms and ERK-phosphorylation were enhanced after 3 μ M NaHS treatment while AKT-phosphorylation was suppressed. NaHS dose-dependently increased the prolif- eration of hASCs while pretreatment with propargylglycine decreased it. Signi fi cance: NaHS pretreatment can increase the survival of therapeutically used human adipose tissue-derived stemcells viaincreased antioxidant defense andimproves the postischemic cardiac derived cells' survival aswell. Proliferation ofhuman adiposetissue-derivedstemcells is enhanced by H 2 S.The underlying mechanisms involve enhanced ERK-phosphorylation and decreased AKT-phosphorylation. Pretreatment with NaHS may represent a simple pharmacological step that may enhance the ef fi cacy of cell-based therapies.

Actions (login required)

Edit Item